January 9, 2018

Summit Announcements
Information from CDC
Information Of Interest


CDC Webinar – Commemoration of the 1918 Flu Pandemic

On January 9 CDC presented a webinar on the significance of the historic 1918 flu pandemic. During the webinar Dr. Dan Jernigan, Director of NCIRD’s Influenza Division, provided a presentation highlighting achievements made over the last 100 years to detect, prevent, and respond to pandemic influenza, as well as future opportunities to improve our pandemic influenza preparedness. The presentation also provided details on some special events being planned to commemorate this historic event and shared ideas and resources for your involvement.

2018 Annual Conference on Vaccinology Research Abstract Submission Deadline Extended to January 17, 2018

The deadline to submit oral and poster presentations for the 2018 Annual Conference on Vaccinology Research (ACVR) has been extended to Wednesday, January 17, 2018 at 11:59 pm PT. (See NFID Tips for Writing and Effective Abstract for assistance.)

Don’t miss this opportunity to present to an international audience of healthcare professionals and researchers from government, industry, and academia at the 2018 ACVR! Please forward this information to interested colleagues and encourage them to submit.

NFID also invites all individuals in the early stages of their career in any field of vaccinology to apply for the Maurice R. Hilleman Early-Stage Career Investigator Award, which includes $10,000 to support research activities.

Call for Nominations: NAIIS Immunization Excellence Awards

The National Adult and Influenza Immunization Summit (NAIIS) is soliciting candidates for the 2018 NAIIS Immunization Excellence Awards. The 2018 awards recognize individuals and organizations that have made extraordinary contributions towards improving vaccination rates within their communities during 2017. The awards focus on individuals and organizations that exemplify the meaning of the “immunization neighborhood” (collaboration, coordination, and communication among immunization stakeholders dedicated to meeting the immunization needs of the patient and protecting the community from vaccine-preventable diseases (VPDs)). Unless an award criteria is specifically focused on influenza, it is the intent of the Summit to recognize broader adult immunization activities.

A National Winner will be selected for each award category, and, where appropriate, an Honorable Mention recipient. The winners will be presented with their awards at the National Adult and Influenza Immunization Summit meeting (to be held in Atlanta, Georgia on May 17-18, 2018 (awards ceremony will be held May 18). The national winner in each category will be invited to present their program at the Summit meeting.

Call for Abstract Submissions: 2018 Healthy Aging Summit

The Office of Disease Prevention and Health Promotion and the Office on Women’s Health within HHS, along with the American College of Preventive Medicine, are now accepting abstracts for oral and poster presentations for the 2018 Healthy Aging Summit. All abstract proposal must be submitted online through the abstracts submission site by February 5, 2018.

Abstracts can be on any of the following tracks:

  • Social and Community Context
  • Maximizing Quality of Life
  • Health and Health Care
  • Neighborhood and Built Environment

The 2018 Healthy Aging Summit, which will take place on July 16–17, 2018 in Washington, DC, will focus on staying healthy while transitioning into older adulthood, and keeping healthy through prevention strategies.


NFID Tdap Awareness Resources

The National Foundation for Infectious Diseases (NFID) is pleased to share a new Tdap awareness campaign that it recently launched in collaboration with Sanofi Pasteur, including a public service announcement video focused on the importance of disease prevention through vaccination.

Pertussis (whooping cough) is a serious infection that spreads easily from person to person. The infection can cause coughing spells that are so severe that it can be hard to breathe, eat, or sleep. Whooping cough may even lead to cracked ribs, pneumonia, or hospitalization. In the past, whooping cough was largely controlled by infant and childhood immunization. It is now known that protection from childhood whooping cough vaccination fades with time and a booster for adolescents and adults is recommended by the Centers for Disease Control and Prevention (CDC). Unfortunately, many remain unvaccinated and at risk for catching and spreading the infection.

Please help NFID spread the word about the importance of whooping cough prevention as follows:

1. ivat video, using sample social media posts (including the images from the Tdap thumbnails highlighting who should be vaccinated and childhood transmission at home) as follows:



  • Whooping cough (pertussis), is a serious infection that spreads easily from person to person. The infection can cause coughing spells that are so severe that it can be hard to breathe, eat, or sleep. Whooping cough may even lead to cracked ribs, pneumonia, or hospitalization. Make sure that you and your loved ones are protected and ask your healthcare provider about staying up-to-date with Tdap vaccines https://www.youtube.com/watch?v=B85TRWMrZh4

2. Share the guest blog post, Protecting Your Children’s Health Through the Holidays, by Danielle Lucia Schaffer (@citygirlgonemom), to help individuals learn about the importance of prevention through vaccination:



3. Follow NFID on Twitter, Facebook, and Instagram and share whooping cough-related posts.


CDC Health Alert Network (HAN) Advisory: Early Season Influenza A(H3N2) Activity and Treatment of Patients with Influenza Antiviral Medications

On December 27, 2017, CDC issued HAN 409 to provide: 1) a notice about increased influenza A (H3N2) activity and its clinical implications; 2) a summary of influenza antiviral drug treatment recommendations; 3) an update about approved treatment drugs and supply this season; and 4) background information for patients about influenza treatment.

This CDC Health Advisory was issued to:

  • Remind clinicians that influenza should be high on their list of possible diagnoses for ill patients because influenza activity is increasing nationwide, and
  • Advise clinicians that all hospitalized patients and all high-risk patients (either hospitalized or outpatient) with suspected influenza should be treated as soon as possible with a neuraminidase inhibitor antiviral. While antiviral drugs work best when treatment is started within 2 days of illness onset, clinical benefit has been observed even when treatment is initiated later.

Seasonal Influenza Surveillance

CDC has released Seasonal Flu Key Points for January 5, 2018. In addition, the FluView report for Week 52 (ending December 30, 2017) has been published.

In a new feature on FluView Interactive, state/jurisdiction level ILI and virologic data are now available for states/jurisdictions who have given CDC approval to display their data.

CDC Press Release: Seasonal Flu Death Estimate Worldwide

According to new estimates based on a robust, multinational survey and published on December 13, 2017, between 291,000 and 646,000 people worldwide die from seasonal influenza-related respiratory illnesses each year, higher than a previous estimate of 250,000 to 500,000. The new estimate, from a collaborative study by CDC and global health partners, appeared in The Lancet. The estimate excludes deaths during pandemics.

Cancer and Flu

CDC recommends that people with cancer or a history of cancer, and people who live with or care for cancer patients and survivors, should get a seasonal flu shot. Immune defenses become weaker with age, which places older people at greater risk of severe illness from flu. Also, aging decreases the body’s ability to have a good immune response after getting a flu shot. Healthcare providers should be aware of the two vaccines designed specifically for people 65 and older.


Summit’s Influenza Vaccine Availability Tracking System (IVATS) is Live for the 2017–2018 season

IVATS serves as a resource for healthcare settings wishing to purchase influenza vaccine. IVATS contains information from approved, enrolled, and participating wholesale vaccine distributors or manufacturers of U.S. licensed influenza vaccine. Ongoing updates will be made throughout the 2017–2018 influenza vaccination season.

Three Slide Decks Available to Support New Standards for Adult Immunization Practice

The Summit’s Access and Collaboration workgroup has developed three separate slide decks with talking notes to support partners and others who wish to present on the Standards to their peers and colleagues. The three audiences targeted by the decks are: healthcare providers; patients/public; and public health. These are now available, along with tips and tools on how to use them, at the Summit website.

Also, do not forget that Medscape has produced two modules to support the implementation of the Standards:

Every Child By Two (ECBT) Compiles Media Information on Its Website

On a daily basis, ECBT assembles significant news media coverage on immunizations in their “Daily Clips.” Summit partners may find this effort useful.

Summit Website Offers Wonderful Resources on Influenza Vaccination

Remember to visit the Summit website for the latest on influenza immunization resources. You also can find archived copies of The Summit Buzz there.


Summit calls are scheduled every Thursday at 3 PM ET, unless cancelled. Calls will resume on Thursday, January 22, 2018. Call summaries are posted to the Summit website shortly after each call. Please email L.J Tan or LaDora Woods if you have any updates on activities to provide the Summit.

Print Friendly, PDF & Email